Back to Agenda
How to promote patient centricity ? - Based on experiences of clinician and head of regulatory agency
Session Chair(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs
European Medicines Agency, Netherlands
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Patient Centricity is becoming more important in pharmaceutical development and also in information sharing areas. In this session, heads of regulatory agencies share keys to patient centricity from their clinical and regulatory experiences.
Speaker(s)
Promoting Patient and Public Involvement in Japan
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Patient engagement, Public engagement Department, Stakeholders and Communication Division
Nathalie Bere, MPH
European Medicines Agency, Netherlands
Patient Engagement
Panelist
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
Have an account?